These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27021761)

  • 21. An economic evaluation of thermostable vaccines in Cambodia, Ghana and Bangladesh.
    Levin A; Levin C; Kristensen D; Matthias D
    Vaccine; 2007 Sep; 25(39-40):6945-57. PubMed ID: 17707556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic review of economic evaluation studies: are vaccination programs efficient in Spain?
    García-Altés A
    Vaccine; 2013 Mar; 31(13):1656-65. PubMed ID: 23370153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
    Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B
    Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Economic evaluation of an infant immunization program in Mexico, based on 13-valent pneumococcal conjugated vaccines].
    Muciño-Ortega E; Mould-Quevedo JF; Farkouh R; Strutton D
    Value Health; 2011; 14(5 Suppl 1):S65-70. PubMed ID: 21839902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critique.
    Grosse SD; Prosser LA; Asakawa K; Feeny D
    Expert Rev Pharmacoecon Outcomes Res; 2010 Jun; 10(3):293-308. PubMed ID: 20545594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
    Armstrong EP
    J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of health utilities across conditions common in paediatric and adult populations.
    Tarride JE; Burke N; Bischof M; Hopkins RB; Goeree L; Campbell K; Xie F; O'Reilly D; Goeree R
    Health Qual Life Outcomes; 2010 Jan; 8():12. PubMed ID: 20105304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility Values for Adults with Unipolar Depression: Systematic Review and Meta-Analysis.
    Mohiuddin S; Payne K
    Med Decis Making; 2014 Jul; 34(5):666-85. PubMed ID: 24695961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validity and interpretation of preference-based measures of health-related quality of life.
    Lenert L; Kaplan RM
    Med Care; 2000 Sep; 38(9 Suppl):II138-50. PubMed ID: 10982099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility value estimates in cardiovascular disease and the effect of changing elicitation methods: a systematic literature review.
    Betts MB; Rane P; Bergrath E; Chitnis M; Bhutani MK; Gulea C; Qian Y; Villa G
    Health Qual Life Outcomes; 2020 Jul; 18(1):251. PubMed ID: 32718355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of cannabinoids for pediatric drug-resistant epilepsy: protocol for a systematic review of economic evaluations.
    Elliott J; McCoy B; Clifford T; Potter BK; Skidmore B; Wells GA; Coyle D
    Syst Rev; 2019 Mar; 8(1):75. PubMed ID: 30917869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review.
    Saokaew S; Rayanakorn A; Wu DB; Chaiyakunapruk N
    Pharmacoeconomics; 2016 Dec; 34(12):1211-1225. PubMed ID: 27510721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health state utility values among children and adolescents with disabilities: protocol for a systematic review.
    Kanya L; Anokye N; Ryan JM
    BMJ Open; 2018 Feb; 8(2):e019978. PubMed ID: 29467137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of childhood rotavirus vaccination in Germany.
    Aidelsburger P; Grabein K; Böhm K; Dietl M; Wasem J; Koch J; Ultsch B; Weidemann F; Wichmann O
    Vaccine; 2014 Apr; 32(17):1964-74. PubMed ID: 24561052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The utility of health states after stroke: a systematic review of the literature.
    Post PN; Stiggelbout AM; Wakker PP
    Stroke; 2001 Jun; 32(6):1425-9. PubMed ID: 11387509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil.
    Sartori AMC; de Soárez PC; Fernandes EG; Gryninger LCF; Viscondi JYK; Novaes HMD
    Vaccine; 2016 Mar; 34(13):1531-1539. PubMed ID: 26899375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What timing of vaccination is potentially dangerous for children younger than 2 years?
    Gras P; Bailly AC; Lagrée M; Dervaux B; Martinot A; Dubos F
    Hum Vaccin Immunother; 2016 Aug; 12(8):2046-2052. PubMed ID: 27215704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do Model-Based Studies in Chronic Obstructive Pulmonary Disease Measure Correct Values of Utility? A Meta-Analysis.
    Moayeri F; Hsueh YS; Clarke P; Dunt D
    Value Health; 2016 Jun; 19(4):363-73. PubMed ID: 27325328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How do physicians immunize their own children? Differences among pediatricians and nonpediatricians.
    Posfay-Barbe KM; Heininger U; Aebi C; Desgrandchamps D; Vaudaux B; Siegrist CA
    Pediatrics; 2005 Nov; 116(5):e623-33. PubMed ID: 16263976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic literature review of utility weights in wet age-related macular degeneration.
    Pearson I; Rycroft C; Irving A; Ainsworth C; Wittrup-Jensen K
    J Med Econ; 2013 Nov; 16(11):1307-16. PubMed ID: 24004384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.